| WFC (n = 30) | Control (n = 30) | Total (n = 60) | X2 | t | P |
---|---|---|---|---|---|---|
Agea | 50.37 (12.50) | 53.90 (10.61) | 52.13 (11.53) | Â | 1.2 | 0.243 |
Sex | Â | Â | Â | Â | Â | Â |
 Male | 16 (53.33) | 15 (50.00) | 31 (51.67) | 0.268 |  | 0.796 |
 Female | 14 (46.67) | 15 (50.00) | 29 (48.33) |  | ||
Course of diseasea | 5.57 (4.94) | 5.87 (5.10) | 5.72 (4.93) | Â | 0.2 | 0.818 |
Pathology | ||||||
 Chronic Gastritisb | ||||||
  Mild | 7 (23.33) | 10 (33.33) | 17 (28.33) | 1.888 |  | 0.596 |
  Moderate | 20 (66.67) | 19 (63.33) | 39 (65.00) |  | ||
  Severe | 2 (6.67) | 1 (3.33) | 3 (5.00) |  | ||
 Active Gastritisb | ||||||
  Mild | 11(36.67) | 7 (23.33) | 18 (30.00) | 1.765 |  | 0.414 |
  Moderate | 3 (10.00) | 2 (6.67) | 5 (8.33) |  | ||
  Severe | 0 (0.00) | 0 (0.00) | 0 (0.00) |  | ||
 Atrophyb | ||||||
  Mild | 14 (46.67) | 19 (63.33) | 33 (55) | 3.000 |  | 0.254 |
  Moderate | 12 (40) | 10 (33.33) | 22 (36.67) |  | ||
  Severe | 4 (13.33) | 1 (3.33) | 5 (8.33) |  | ||
 Intestinal metaplasiab | ||||||
  Mild | 16 (53.33) | 21 (70.00) | 37 (61.67) | 2.739 |  | 0.493 |
  Moderate | 10 (33.33) | 7 (23.33) | 17 (28.33) |  | ||
  Severe | 3 (10.00) | 2 (6.67) | 5 (8.33) |  | ||
 Dysplasiab | ||||||
  Mild | 6 (20.00) | 4 (13.33) | 10 (16.67) | 2.632 |  | 0.235 |
  Moderate | 0 (0.00) | 0 (0.00) | 0 (0.00) |  | ||
  Severe | 0 (0.00) | 0 (0.00) | 0 (0.00) |  | ||
 Aggregate scorec | 5.70 (2.00) | 4.97 (1.63) |  |  | 1.6 | 0.125 |
Clinical Symptoms | ||||||
 Aggregate scorec | 15.32 (5.71) |  | 15.92 (5.43) |  | 3.5 | 0.929 |